J&J succeeds in overturning a $151 million hip implant ruling
Category: #health  By Shikha Sinha  Date: 2018-04-30
  • share
  • Twitter
  • Facebook
  • LinkedIn

J&J succeeds in overturning a $151 million hip implant ruling

Johnson & Johnson, the multinational pharmaceutical and biotechnology major, has apparently announced that it has acquired a positive verdict by U.S. appellate court on Wednesday. As per reliable sources, the latest judgment overturns the previous ruling which had awarded USD 151 million to five people who alleged that they suffered grave injuries due to the firm’s Pinnacle hip implant devices.

According to the 5th U.S. Circuit Court of Appeals, a new trial was required in the case as the previous judge delivered evidentiary verdicts and the defective marketing claims made by plaintiffs proved to be legally insufficient.

Writing for the three-judge panel, U.S. Circuit Court Judge, Jerry Smith reportedly stated that U.S. District Judge of Dallas Ed Kinkeade erred in allowing the lawyers of hip implant receivers to present ‘inflammatory character evidence’ regarding Johnson & Johnson.

He further commented that the most problematic evidence presented in the court was pertaining to the allegation that J&J paid bribes to the henchmen of Saddam Hussein in Iraq. Reportedly, these allegations stem from the firm’s 2011 deal to pay USD 70 million to resolve foreign bribery investigations in the United States.

The case at hand was a trial aimed at allowing both the parties to commence potential settlement talks and gauge the value of the remaining claims, claim reliable sources.

Speaking on the latest verdict, advocate for J&J and its DePuy unit, John Beisner was quoted stating that the ruling reinforces the fact that the lawsuit was stuffed with faults which made it almost unfeasible for J&J to get a fair trial.

Reportedly, DePuy halted the sale of Pinnacle devices in the year 2013 post the decision of Food and Drug Administration (FDA) to strengthen its regulatory guidelines regarding artificial hip replacement. As per a statement released by J&J, the Pinnacle devices are now the subject of around 10,000 product liability lawsuits.



About Author

Shikha Sinha

Email: [email protected]   

Shikha Sinha

Shikha currently manages content operations for a series of news and business portals including MSF, Algosonline, and the like. An electrical & electronics engineer by education, she has prior experience in content & technology writing, content marketing, market resea...

Read More

More News By Shikha Sinha

Altimmune inks deal to acquire Spitfire Pharma and its NASH candidate
Altimmune inks deal to acquire Spitfire Pharma and its NASH candidate
By Shikha Sinha

Altimmune, Inc., a clinical stage biopharma company, has recently confirmed the closing of a formerly announced acquisition of Spitfire Pharma, Inc., including the strong GLP-1/Glucagon receptor co-agonist product cand...

NeurologyLive expands SAP program by partnering with Cleveland Clinic
NeurologyLive expands SAP program by partnering with Cleveland Clinic
By Shikha Sinha

NeurologyLive has reportedly added the Cleveland Clinic to its Strategic Alliance Partnership (SAP) program. Michael J. Hennessy Jr., President of NeurologyLive’s parent company MJH Associates Inc., said in a sta...

Neurocrine, Voyager reveal VY-AADC’s Phase I results at AAN 2019
Neurocrine, Voyager reveal VY-AADC’s Phase I results at AAN 2019
By Shikha Sinha

Neurocrine Biosciences Inc., along with Voyager Therapeutics Inc., has reportedly announced the Phase 1 results from the VY-AADC trial in eight patients suffering from Parkinson’s disease. Apparently, the patient...